Mednax Stock Hits New 52-Week High (MD)

NEW YORK ( TheStreet) -- Mednax (NYSE: MD) hit a new 52-week high Friday as it is currently trading at $75.53, above its previous 52-week high of $75.47 with 145,945 shares traded as of 12:30 p.m. ET. Average volume has been 328,600 shares over the past 30 days.

Mednax has a market cap of $3.49 billion and is part of the health care sector and health services industry. Shares are up 3.2% year to date as of the close of trading on Thursday.

MEDNAX, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty, and anesthesia physician services in the United States and Puerto Rico. The company has a P/E ratio of 16.5, above the average health services industry P/E ratio of 16.2 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Mednax as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Mednax Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Why the Boardroom Doesn't Need Ivy League Degrees

Mednax: Solid Growth at a Good Price

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

How to Invest in Your Favorite MD